Click here to post a new related report
Canadian Business Online: Vivus says it will announce data from 2 clinical trials of obesity drug candidate Qnexa
Drugmaker Vivus Inc. says it plans to report results from two late-stage studies of its obesity drug candidate Qnexa Wednesday morning...Vivus reported two successful midstage trials in June, saying Qnexa helped type 2 diabetes patients lower their blood sugar levels and lose weight.
-
- Share:
-
-
-
-
-
-
Reach -
Credibility
-
READ MORE:
News Stories
- News Source: Androscoggin News | 3 months agoDrugmaker Vivus Inc. says it plans to report results from two late-stage studies of its obesity drug candidate Qnexa Wednesday morning...Vivus reported two successful midstage trials in June, saying Qnexa helped type 2 diabetes patients lower their...
- News Source: Androscoggin News | 3 months agoQnexa(TM) phase 3 obesity clinical trials on September 9th prior to market open. The announcement will be followed by a webcast and conference call at 8:00 a.m...Conference Call Information Domestic callers: 1-800-967-7185 International callers: 1-...
Site Links
Site Topics
Contributions
- Report Your News
- Add your voice and contribute via your cellphone - check out how to Report News via Your Cellphone
- Blog Widget
- Widget for Blog Owner
